×
About 19,784 results

ALLMedicine™ Fibromyalgia Center

Research & Reviews  8,717 results

Substituting Cannabidiol for Opioids and Pain Medications Among Individuals with Fibrom...
https://doi.org/10.1016/j.jpain.2021.04.011
The Journal of Pain; Boehnke KF, Gagnier JJ et. al.

May 16th, 2021 - People report substituting cannabis for pain medications, but whether cannabidiol (CBD) is used similarly remains unknown. CBD products can be CBD alone (isolate), hemp extract (containing <0.3% Δ-9-tetrahydrocannabinol [THC], other cannabinoids, ...

BMI but not age and sex negatively impact on the outcome of pharmacotherapy in fibromya...
https://doi.org/10.1080/17512433.2021.1929923
Expert Review of Clinical Pharmacology; Migliorini F, Maffulli N et. al.

May 15th, 2021 - The impact of sex, age, body mass index (BMI) in fibromyalgia is still unclear. A systematic review was conducted to investigate whether sex, age and BMI influence the clinical outcomes and rate of adverse events. The present study was performed a...

High Attention-Deficit/Hyperactivity Disorder Scale Scores Among Patients with Persiste...
https://www.ncbi.nlm.nih.gov/pubmed/33988951
Pain Physician; Kasahara S, Niwa SI et. al.

May 14th, 2021 - Associations between attention-deficit/hyperactivity disorder (ADHD) and chronic pain disorders, such as fibromyalgia, have been reported. However, associations between persistent chronic nonspecific low back pain (CNLBP) and ADHD have not yet bee...

Prediction of Differential Pharmacologic Response in Chronic Pain Using Functional Neur...
https://doi.org/10.1002/art.41781
Arthritis & Rheumatology (Hoboken, N.J.); Ichesco E, Peltier SJ et. al.

May 13th, 2021 - There is increasing demand for prediction of chronic pain treatment outcomes using machine-learning models, in order to improve suboptimal pain management. In this exploratory study, we used baseline brain functional connectivity patterns from chr...

see more →

Guidelines  7 results

Adult attention deficit hyperactivity disorder in patients with fibromyalgia syndrome: Assessment and disabilities
https://pubmed.ncbi.nlm.nih.gov/33127072/
Journal of Psychiatric Research; Stefano P

Oct 23rd, 2020 - In the broader list of cognitive concerns, neuropsychological testing has shown that attentional impairment may have a specific burden in Fibromyalgia Syndrome (FMS).

Acupuncture for Pain
https://www.aafp.org/afp/2019/0715/p89.html
American Family Physician; Kelly,R.,et al

Jul 14th, 2019 - Acupuncture has been increasingly used as an integrative or complementary therapy for pain. It is well-tolerated with little risk of serious adverse effects. Traditional acupuncture and nontraditional techniques, such as electroacupuncture and dry...

Arthritis Prevalence Statistics
https://www.rheumatology.org/Learning-Center/Statistics/Prevalence-Statistics

Jun 26th, 2019 - View overall prevalence of arthritis and rheumatic diseases as well as prevalence among specific racial and ethnic groups.

New Treatment Guidelines for Sjögren's Syndrome
https://www.sjogrens.org/files/research/RheumatologyCPG.pdf

Feb 13th, 2018 - Among all the chronic autoimmune rheumatic disorders, Sjo¨ gren’s disease (SD) is among the most difficult to evaluate and manage. Clinicians are frequently challenged to differentiate symptoms related to disease activity from those that result fr...

2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: exe...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673928
Pain Research & Management; Fitzcharles MA, Ste-Marie PA et. al.

Jun 11th, 2013 - Recent neurophysiological evidence attests to the validity of fibromyalgia (FM), a chronic pain condition that affects >2% of the population. To present the evidence-based guidelines for the diagnosis, management and patient trajectory of individu...

see more →

Drugs  371 results see all →

Clinicaltrials.gov  9,729 results

Substituting Cannabidiol for Opioids and Pain Medications Among Individuals with Fibrom...
https://doi.org/10.1016/j.jpain.2021.04.011
The Journal of Pain; Boehnke KF, Gagnier JJ et. al.

May 16th, 2021 - People report substituting cannabis for pain medications, but whether cannabidiol (CBD) is used similarly remains unknown. CBD products can be CBD alone (isolate), hemp extract (containing <0.3% Δ-9-tetrahydrocannabinol [THC], other cannabinoids, ...

BMI but not age and sex negatively impact on the outcome of pharmacotherapy in fibromya...
https://doi.org/10.1080/17512433.2021.1929923
Expert Review of Clinical Pharmacology; Migliorini F, Maffulli N et. al.

May 15th, 2021 - The impact of sex, age, body mass index (BMI) in fibromyalgia is still unclear. A systematic review was conducted to investigate whether sex, age and BMI influence the clinical outcomes and rate of adverse events. The present study was performed a...

High Attention-Deficit/Hyperactivity Disorder Scale Scores Among Patients with Persiste...
https://www.ncbi.nlm.nih.gov/pubmed/33988951
Pain Physician; Kasahara S, Niwa SI et. al.

May 14th, 2021 - Associations between attention-deficit/hyperactivity disorder (ADHD) and chronic pain disorders, such as fibromyalgia, have been reported. However, associations between persistent chronic nonspecific low back pain (CNLBP) and ADHD have not yet bee...

Prediction of Differential Pharmacologic Response in Chronic Pain Using Functional Neur...
https://doi.org/10.1002/art.41781
Arthritis & Rheumatology (Hoboken, N.J.); Ichesco E, Peltier SJ et. al.

May 13th, 2021 - There is increasing demand for prediction of chronic pain treatment outcomes using machine-learning models, in order to improve suboptimal pain management. In this exploratory study, we used baseline brain functional connectivity patterns from chr...

see more →

News  895 results

Addiction Medication Promising for Chronic, Refractory Pain
https://www.medscape.com/viewarticle/950263

Apr 29th, 2021 - Low-dose naltrexone (LDN) may be effective in the treatment of refractory chronic pain, early research suggests. Preliminary data from a retrospective chart review of patients with chronic pain showed those who received LDN experienced significant...

Osteoporosis Drugs Don't Worsen COVID-19 Risk, May Help
https://www.staging.medscape.com/viewarticle/941110

Nov 16th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. New observational data are the first to support recommendations to continue osteoporosis medications during the COVID-19 pandemic, and even sugges...

Most Fibromyalgia Treatments Not Supported by High-Quality Evidence
https://www.medscape.com/viewarticle/940007

Oct 29th, 2020 - NEW YORK (Reuters Health) - Most therapies now available for fibromyalgia are not backed by high-quality evidence for their effectiveness in reducing pain or improving quality of life (QOL), according to a new research review. "Out of 65 different...

Adult attention deficit hyperactivity disorder in patients with fibromyalgia syndrome: Assessment and disabilities
https://pubmed.ncbi.nlm.nih.gov/33127072/
Journal of Psychiatric Research; Stefano P

Oct 23rd, 2020 - In the broader list of cognitive concerns, neuropsychological testing has shown that attentional impairment may have a specific burden in Fibromyalgia Syndrome (FMS).

Chronic Pain May Be Effectively Treated Using Placebo Effect
https://www.medscape.com/viewarticle/934041

Jul 15th, 2020 - According to a new study published in the journal Pain, placebo pain relief could be reproduced in patients with chronic pain compared with healthy volunteers. Sixty patients with osteoarthritis and 79 patients with fibromyalgia as well as 98 heal...

see more →

Patient Education  65 results see all →